Pharmaresearch Bio Co (XKRX:217950) Short-Term Capital Lease Obligation : ₩190 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Short-Term Capital Lease Obligation?

Pharmaresearch Bio Co's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩190 Mil.

Pharmaresearch Bio Co's quarterly Short-Term Capital Lease Obligation declined from Dec. 2022 (₩193 Mil) to Dec. 2023 (₩179 Mil) but then increased from Dec. 2023 (₩179 Mil) to Dec. 2024 (₩190 Mil).

Pharmaresearch Bio Co's annual Short-Term Capital Lease Obligation declined from Dec. 2022 (₩193 Mil) to Dec. 2023 (₩179 Mil) but then increased from Dec. 2023 (₩179 Mil) to Dec. 2024 (₩190 Mil).

Pharmaresearch Bio Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Pharmaresearch Bio Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Short-Term Capital Lease Obligation Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

81.62

75.36

192.63

179.15

190.25

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial			81.62	75.36	192.63	179.15	190.25

Pharmaresearch Bio Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Pharmaresearch Bio Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines